Janus Henderson Group Plc

13F Holdings History for Monopar Therapeutics - Common Stock, $0.001 par value (MNPR)

Symbol: MNPR on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Ownership: 1.17M shares
Security Ownership: 19.2%

Shares, Excluding Options vs Price

Value, Excluding Options

JANUS HENDERSON GROUP PLC ownership in Monopar Therapeutics Common Stock, $0.001 par value (MNPR)

2025-08-14 - JANUS HENDERSON GROUP PLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.17M shares of Monopar Therapeutics Common Stock, $0.001 par value (MNPR). This represents 19.2% percent ownership of the company. In their previous filing dated 2025-05-14, JANUS HENDERSON GROUP PLC had reported owning 1.13M shares, indicating an increase of 3.35% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
JANUS HENDERSON GROUP PLC	19.2%	+3.16%	$42.3M	1.17M	+37,962	+3.35%	$36.06	13G/A	6/30/2025	14 Aug 2025 10:58:13
JANUS HENDERSON GROUP PLC	18.6%	+8.24%	$39.6M	1.13M	+87,507	+8.36%	$34.89	13G/A	3/31/2025	14 May 2025 11:59:32
JANUS HENDERSON GROUP PLC	17.2%		$36.5M	1.05M			$34.89	13G/A	12/31/2024	8 Jan 2025 11:38:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.02%	+0%	$41.6M	1.17M	+37,962	+3.35%	$35.48	Q2 2025
3/31/2025	0.03%	+0%	$45.6M	1.13M	+87,507		$40.20	Q1 2025
12/31/2024	0.01%	+0.01%	$23.4M	1.05M	+1,046,899	NEW	$22.39	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.